SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
| Date of Report (Date of earliest event reported) | June 15, 2001 |
CardioGenesis Corporation
| California (State or other jurisdiction of incorporation) |
0-28288 (Commission file number) |
77-0223740 (IRS employer identification no.) |
||
| 1049 Kiel Court, Sunnyvale, California (Address of principal executive offices) |
94089 (Zip code) |
| Registrant’s telephone number, including area code | (408) 548-2100 |
Eclipse Surgical Technologies, Inc.
| Item 5. Other Events. | ||||||||
| Item 7. Exhibits. | ||||||||
| SIGNATURE | ||||||||
| EXHIBIT INDEX | ||||||||
| EXHIBIT 99.1 | ||||||||
Item 5. Other Events.
The Registrant’s shareholders, at the Annual Shareholder’s Meeting on June 15, 2001, approved an amendment to the Articles of Incorporation to change the name of the Registrant from Eclipse Surgical Technologies, Inc. to CardioGenesis Corporation. The Registrant anticipates that the trading symbol of its common stock on the Nasdaq National Market will be changed from ESTI to CGCP, effective with the opening of the market on Thursday, June 21, 2001.
The Press Release, dated June 18, 2001, is attached hereto as Exhibit 99.1 to this current report on Form 8-K.
Item 7. Exhibits.
(c) Exhibits:
99.1 Press Release, dated June 18, 2001:
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: June 20, 2001 | ||
| CARDIOGENESIS CORPORATION | ||
| (Registrant) | ||
| By: | /s/ J. STEPHEN WILKINS | |
| J. Stephen Wilkins | ||
| Chief Financial Officer | ||
EXHIBIT INDEX
| Sequentially | ||||||
| Numbered | ||||||
| Exhibit No. | Description | Page | ||||
99.1 |
Press Release, dated June 18, 2001. |
|||||